Gland Pharma Limited — Others, 03-12-2024: Change in Management

Mr. Ankit Gupta, the Vice President of Strategy, Investments, and Investor Relations at Gland Pharma, has resigned to explore new opportunities. His resignation has been accepted, and he will officially conclude his duties on December 31, 2024. Gupta's departure may prompt strategic adjustments within the company, especially in investor relations and strategic planning. This change could create a potential risk regarding continuity in leadership, but it also presents an opportunity for Gland Pharma to bring in new talent that aligns with its future growth objectives. Investor sentiment may remain cautious as the company navigates this transition.